|
1
|
Shah S and Frieden IJ: Treatment of
infantile hemangiomas with beta-blockers: A review. Skin Therapy
Lett. 18:5–7. 2013.PubMed/NCBI
|
|
2
|
Williams EF III, Hochman M, Rodgers BJ,
Brockbank D, Shannon L and Lam SM: A psychological profile of
children with hemangiomas and their families. Arch Facial Plast
Surg. 5:229–234. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Manunza F, Syed S, Laguda B, Linward J,
Kennedy H, Gholam K, Glover M, Giardini A and Harper JI:
Propranolol for complicated infantile haemangiomas: A case series
of 30 infants. Br J Dermatol. 162:466–468. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Léauté-Labrèze C, de la Roque Dumas E,
Hubiche T, Boralevi F, Thambo JB and Taïeb A: Propranolol for
severe hemangiomas of infancy. N Engl J Med. 358:2649–2651. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Storch CH and Hoeger PH: Propranolol for
infantile haemangiomas: Insights into the molecular mechanisms of
action. Br J Dermatol. 163:269–274. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Haggstrom AN, Drolet BA, Baselga E,
Chamlin SL, Garzon MC, Horii KA, Lucky AW, Mancini AJ, Metry DW,
Newell B, et al: Prospective study of infantile hemangiomas:
Clinical characteristics predicting complications and treatment.
Pediatrics. 118:882–887. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Frieden IJ, Haggstrom AN, Drolet BA,
Mancini AJ, Friedlander SF, Boon L, Chamlin SL, Baselga E, Garzon
MC, Nopper AJ, et al: Infantile hemangiomas: Current knowledge,
future directions. Proceedings of a research workshop on infantile
hemangiomas, April 7–9, 2005, Bethesda, MA. Pediatr Dermatol.
22:383–406. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chim H, Armijo BS, Miller E, Gliniak C,
Serret MA and Gosain AK: Propranolol induces regression of
hemangioma cells through HIF-1α-mediated inhibition of VEGF-A. Ann
Surg. 256:146–156. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Taraboletti G, Sonzogni L, Vergani V,
Hosseini G, Ceruti R, Ghilardi C, Bastone A, Toschi E, Borsotti P,
Scanziani E, et al: Posttranscriptional stimulation of endothelial
cell matrix metalloproteinases 2 and 1 by endothelioma cells. Exp
Cell Res. 258:384–394. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Arevalo JF, Shields CL, Shields JA, Hykin
PG and De Potter P: Circumscribed choroidal hemangioma:
Characteristic features with indocyanine green videoangiography.
Ophthalmology. 107:344–350. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Vergani V, Garofalo A, Bani MR, Borsotti
P, Parker MP, Drudis T, Mazzarol G, Viale G, Giavazzi R,
Stetler-Stevenson WG, et al: Inhibition of matrix
metalloproteinases by over-expression of tissue inhibitor of
metalloproteinase-2 inhibits the growth of experimental
hemangiomas. Int J Cancer. 91:241–247. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chai Q, Chen WL, Huang ZQ, Zhang DM, Fan S
and Wang L: Preliminary experiences in treating infantile
hemangioma with propranolol. Ann Plast Surg. 72:169–172. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Selmin A, Foltran F, Chiarelli S, Ciullo R
and Gregori D: An epidemiological study investigating the
relationship between chorangioma and infantile hemangioma. Pathol
Res Pract. 210:548–553. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Adler AP, Daly C, Parveen AA, Nevins T,
Shan J, Fairhurst J, Huang T, Martin J, Papadopoulos N, Yancopoulos
GD, et al: Blockade of angiopoietin-2 or Tie2 is equally effective
at inhibiting tumor growth and reducing tumor vessel density in
most human tumor xenograft models. Cancer Res (AACR Annual Meeting
2014). 74 19 Suppl:Abst 4492. 2014.
|
|
15
|
Lomas-Neira JL, Heffernan DS, Ayala A and
Monaghan SF: Blockade of endothelial growth factor, angiopoietin-2,
reduces indices of ARDS and mortality in mice resulting from the
dual-insults of hemorrhagic shock and sepsis. Shock. 45:157–165.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tal R, Seifer DB, Grazi RV and Malter HE:
Angiopoietin-1 and angiopoietin-2 are altered in polycystic ovarian
syndrome (PCOS) during controlled ovarian stimulation. Vasc Cell.
5:182013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yue CH, Shu H, Feng JH and Zhang DY: The
efficacy and safety of oral propranolol combination with topical
application of timolol maleate eye drops on infant hemangioma. J
Dermatol Venereol. 27:179–184. 2015.
|
|
18
|
Lee D, Boscolo E, Durham JT, Mulliken JB,
Herman IM and Bischoff J: Propranolol targets the contractility of
infantile haemangioma-derived pericytes. Br J Dermatol.
171:1129–1137. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Emiralioğlu N, Oğuz B, Akyüz C, Yalçın B,
Kiper N, Ersöz DD, Yalçın E and Özçelik U: Successful treatment of
pulmonary hemangioma with propranolol. Pediatr Pulmonol.
49:829–833. 2014. View Article : Google Scholar : PubMed/NCBI
|
